BioVaxys Announces BVX-0320 Poster Presentation at ISIRV-WHO Virtual Conference |
| October 08, 2021 | October 2021 Bond Updates |
|
SARS-Cov-2 spike protein vaccine induced strong antibody and T cell responses in murine model VANCOUVER, BC, Oct. 8, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that a poster highlighting its preclinical data... |
| View more at: https://www.prnewswire.com:443/news-releases/biovaxys-announces-bvx-0320-poster-presentation-at-isirv-who-virtual-conference-301395772.html |
| Related News |
|